Close

Shire (SHPG) Announces Updated Vyvanse Labeling

Go back to Shire (SHPG) Announces Updated Vyvanse Labeling

Shire Announces Update to Vyvanse® (lisdexamfetamine dimesylate) U.S. Labeling to Include New Longer-Term Maintenance of Efficacy Data in Adults with Moderate to Severe Binge Eating Disorder

October 17, 2016 7:00 AM EDT

LEXINGTON, Massachusetts, October 17, 2016 /PRNewswire/ --

Labeling Update Based on Maintenance of Efficacy Data from a 38-Week Phase 3 Study 

For U.S. Audiences Only - Shire plc (LSE: SHP, NASDAQ:... More